Literature DB >> 17212732

Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.

J H Payne1, R M Maclean, K K Hampton, A J Baxter, M Makris.   

Abstract

Haemoperitoneum secondary to ruptured corpus luteum is a rare complication for women on anticoagulants and with certain congenital bleeding disorders. A surgical approach is often taken, leading to oophorectomy in many cases. We describe three patients presenting with haemoperitoneum in association with factor VII deficiency, factor X deficiency and sitosterolaemia. In two of the patients, recurrent episodes occurred prior to introduction of the oral contraceptive pill. Conservative management with blood product and factor concentrate support was successful in avoiding surgery in three of the five episodes of bleeding. These cases demonstrate that preservation of ovarian function is possible with a conservative approach and recurrent episodes may be prevented by suppression of ovulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17212732     DOI: 10.1111/j.1365-2516.2006.01399.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  4 in total

Review 1.  Hemorrhagic corpus luteum: Clinical management update.

Authors:  Mykhailo V Medvediev; Antonio Malvasi; Sarah Gustapane; Andrea Tinelli
Journal:  Turk J Obstet Gynecol       Date:  2020-12-10

2.  An Unusual Presentation of a Corpus Luteum Rupture.

Authors:  Parth Godhiwala; Himanshi Agarwal; Sourya Acharya; Neema Acharya; Vivek Lahane
Journal:  Gynecol Minim Invasive Ther       Date:  2022-02-14

3.  [Congenital factor X deficiency: a retrospective analysis of 11 cases].

Authors:  R W Li; X F Liu; F Xue; Y F Chen; W Liu; R F Fu; L Zhang; R C Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-01-14

Review 4.  Corpus luteum hemorrhage with acquired hemophilia A: a case report and literature review.

Authors:  Xiaofei Xie; Shaoru Jiang
Journal:  BMC Womens Health       Date:  2022-10-11       Impact factor: 2.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.